A multilevel analysis of trimethoprim and ciprofloxacin prescribing and resistance of uropathogenic Escherichia coli in general practice

Journal of Antimicrobial Chemotherapy

Volumn 65, Issue 7, 2010, Pages 1514-1520

  Vellinga, Akke ^a   Murphy, Andrew W ^a   Hanahoe, Belinda ^b   Bennett, Kathleen ^c   Cormican, Martin ^a,b  

^a NATIONAL UNIVERSITY OF IRELAND   (Ireland)

^b UNIVERSITY HOSPITAL GALWAY   (Ireland)

^c TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

Community; Quinolones; UTIs

Indexed keywords

CIPROFLOXACIN; TRIMETHOPRIM; ANTIINFECTIVE AGENT;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL COUNT; BACTERIUM ISOLATE; CONTROLLED STUDY; DISK DIFFUSION; ESCHERICHIA COLI; FEMALE; GENERAL PRACTICE; HUMAN; IRELAND; MAJOR CLINICAL STUDY; MALE; PRESCRIPTION; PRIMARY MEDICAL CARE; RISK FACTOR; SOCIAL STATUS; URINALYSIS; ADOLESCENT; DRUG EFFECTS; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MIDDLE AGED; MULTILEVEL ANALYSIS; PROCEDURES; RETROSPECTIVE STUDY; STATISTICS AND NUMERICAL DATA; URINARY TRACT INFECTION; UROPATHOGENIC ESCHERICHIA COLI; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; CIPROFLOXACIN; DRUG PRESCRIPTIONS; DRUG RESISTANCE, BACTERIAL; FAMILY PRACTICE; FEMALE; HUMANS; IRELAND; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MULTILEVEL ANALYSIS; RETROSPECTIVE STUDIES; TRIMETHOPRIM; URINARY TRACT INFECTIONS; UROPATHOGENIC ESCHERICHIA COLI; YOUNG ADULT;

EID: 77954212233     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkq149     Document Type: Article

References (31)

1. Royal College of Physicians of Ireland Policy Group on Healthcare-Associated Infection (HCAI). Antibiotic Use and the Implications for Healthcare-associated Infection. Dublin, Ireland: RCPI, 2009.
2. van de Sande-Bruinsma N, Grundmann H, Verloo D, et al. Antimicrobial drug use and resistance in Europe. Emerg Infect Dis 2008; 14: 1722-30.
3. European Surveillance of Antimicrobial Consumption. Core Data Collection: Country Data, 2006. http://www.esac.ua.ac.be (21 October 2009, date last accessed).
4. Goossens H, Ferech M, Vander Stichele R, et al. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet 2005; 365: 579-87.
5. Donnan PT, Wei L, Steinke DT, et al. Presence of bacteriuria caused by trimethoprim resistant bacteria in patients prescribed antibiotics: multilevel model with practice and individual patient data. BMJ 2004; 328: 1297.
6. Butler CC, Dunstan F, Heginbothom M, et al. Containing antibiotic resistance: decreased antibiotic-resistant coliform urinary tract infections with reduction in antibiotic prescribing by general practices. Br J Gen Pract 2007; 57: 785-92.
7. Simpson SA, Wood F, Butler CC. General practitioners' perceptions of antimicrobial resistance: a qualitative study. J Antimicrob Chemother 2007; 59: 292-6.
8. Cotter M, Daly L. Antibiotic prescription practices of general practitioners. Ir Med J 2007; 100: 598-601.
9. Dellit TH, Owens RC, McGowan JE Jr, et al. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis 2007; 44: 159-77.
10. Foxman B. Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Am J Med 2002; 113 Suppl 1A: 5S-13S.
11. Hooton TM, Besser R, Foxman B, et al. Acute uncomplicated cystitis in an era of increasing antibiotic resistance: a proposed approach to empirical therapy. Clin Infect Dis 2004; 39: 75-80.
12. Sobel JD, Kaye D. Urinary tract infections. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and Practice of Infectious Diseases. 6th edn. Philadelphia, PA: Elsevier, 2005.
13. . Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Disc Susceptibility Tests-Fifteenth Edition: Approved Standard M2-A8, Table 2C. CLSI, Wayne, PA, 2005.
14. Colombo F, Tapay N. Private Health Insurance in Ireland: A Case Study. OECD Health Working Papers: OECD, Directorate for Employment, Labour and Social Affairs, DELSA/ELSA/WD/HEA(2004)1, 2004.
15. Kelly A. SAHRU Deprivation Index Based on the 2006 Census. http://www.sahru.tcd.ie/ (24 February 2009, date last accessed).
16. Larsen K, Petersen JH, Budtz-Jorgensen E, et al. Interpreting parameters in the logistic regression model with random effects. Biometrics 2000; 56: 909-14.
17. Merlo J, Chaix B, Ohlsson H, et al. A brief conceptual tutorial of multilevel analysis in social epidemiology: using measures of clustering in multilevel logistic regression to investigate contextual phenomena. J Epidemiol Community Health 2006; 60: 290-7.
18. Browne WJ. MCMC Estimation in MLwiN, Version 2.0. London, UK: Centre for Multilevel Modelling, Institute of Education, University of London, 2003.
19. Rasbash JR, Browne WJ. A User's Guide to MLwiN, Version 2.0. London, UK: Centre for Multilevel Modelling, Institute of Education, University of London, 2003.
20. Magee JT, Pritchard EL, Fitzgerald KA, et al. Antibiotic prescribing and antibiotic resistance in community practice: retrospective study, 1996-8. BMJ 1999; 319: 1239-40.
21. Priest P, Yudkin P, McNulty C, et al. Antibacterial prescribing and antibacterial resistance in English general practice: cross sectional study. BMJ 2001; 323: 1037-41.
22. Gottesman BS, Carmeli Y, Shitrit P, et al. Impact of quinolone restriction on resistance patterns of Escherichia coli isolated from urine by culture in a community setting. Clin Infect Dis 2009; 49: 869-75.
23. McCormick AW, Whitney CG, Farley MM, et al. Geographic diversity and temporal trends of antimicrobial resistance in Streptococcus pneumoniae in the United States. Nat Med 2003; 9: 424-30.
24. Garcia-Rey C, Martin-Herrero JE, Baquero F. Antibiotic consumption and generation of resistance in Streptococcus pneumoniae: the paradoxical impact of quinolones in a complex selective landscape. Clin Microbiol Infect 2006; 12 Suppl 3: 55-66.
25. Chulain MN, Murray AM, Corbett-Feeney G, et al. Antimicrobial resistance in E. coli associated with urinary tract infection in the west of Ireland. Ir J Med Sci 2005; 174:6-9.
26. Emmerson AM, Jones AM. The quinolones: decades of development and use. J Antimicrob Chemother 2003; 51 Suppl 1: 13-20.
27. Strahilevitz J, Jacoby GA, Hooper DC, et al. Plasmid-mediated quinolone resistance: a multifaceted threat. Clin Microbiol Rev 2009; 22: 664-89.
28. Austin DJ, Kristinsson KG, Anderson RM. The relationship between the volume of antimicrobial consumption in human communities and the frequency of resistance. Proc Natl Acad Sci USA 1999; 96: 1152-6.
29. Enne VI, Livermore DM, Stephens P, et al. Persistence of sulphonamide resistance in Escherichia coli in the UK despite national prescribing restriction. Lancet 2001; 357: 1325-8.
30. Nasrin D, Collignon PJ, Roberts L, et al. Effect of b-lactam antibiotic use in children on pneumococcal resistance to penicillin: prospective cohort study. BMJ 2002; 324: 28-30.
31. Sundqvist M, Geli P, Andersson DI, et al. Little evidence for reversibility of trimethoprim resistance after a drastic reduction in trimethoprim use. J Antimicrob Chemother 2010; 65: 350-60.